Baseimmune
Uses computational design and protein engineering to create custom antigens for vaccines and active immunotherapies.
baseimmune.co.uk ↗Why it's here
Raised an $11.3M Series A co-led by MSD Global Health Innovation Fund and IQ Capital in February 2024.
source: biospace.com- Focus
- AI immunotherapy
- Founded
- 2019
- Latest round
- Series A, $11.3M, Feb 2024
- Staff (Companies House accounts)
- 21, average over the period to 31 Dec 2025source: find-and-update.company-information.service.gov.uk
- London office
- Apex, 1 Tribeca Walk, London, Camden NW1 0QEsource: baseimmune.co.uk
- London presence
- HQsource: baseimmune.co.uk
- Investors
- IQ Capital (lead), MSD Global Health Innovation Fund (lead), Beast Ventures, Creator Fund, Hoxton Ventures, Maki.vcsource: biospace.com
- Area
- Camden
- Nearest station
- Mornington Crescent, 592 m
- Visas
- Licensed visa sponsor, listed as Baseimmune Ltdsource: gov.uk
- Elsewhere
- LinkedIn ↗
Verified 7 Oct 2026. How we verify · Suggest a fix
For Baseimmune
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/baseimmune"><img src="https://londonmempool.co.uk/badge/baseimmune.svg" alt="Baseimmune is listed on London Mempool" width="357" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.